An anonymous director reports

CANOPY GROWTH ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL SHAREHOLDER MEETING

Canopy Growth Corp. has released the voting results from its annual general and special meeting of shareholders held on Sept. 15, 2022.

A total of 256,426,802 common shares of the company, representing 53.42 per cent of the issued and outstanding common shares of the company, were voted in connection with the meeting by shareholders and proxy holders.

All of the matters put forward before the company's shareholders for consideration and approval, as set out in the company's definitive proxy statement dated July 28, 2022, were approved by the requisite majority of votes cast at the meeting, as further detailed below.

Each of the directors listed as a nominee in the proxy statement was elected at the meeting to serve as a director of the company until the company's next annual shareholders meeting or until his or her successor is duly elected or appointed. The detailed results of the vote for the election of directors held at the meeting are set out in the associated table.

Canopy Growth shareholders also approved the reappointment of KPMG LLP as the company's auditor for the 2023 fiscal year and authorized the board of directors to fix its remuneration.

In addition, Canopy Growth shareholders approved the renewal of the company's employee stock purchase plan.

Canopy Growth shareholders also approved an advisory (non-binding) resolution on the compensation of the company's named executive officers.

For complete results on all matters voted on at the meeting, please consult the company's report of voting results which will be filed on the company's SEDAR profile, and the company's Form 8-K which will be filed on EDGAR.

About Canopy Growth Corp.

Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, the company offers product varieties in high-quality dried flower, oil, soft-gel capsule, infused beverage, edible and topical formats, as well as vaporizer devices by Canopy Growth and industry leader Storz & Bickel. The company's global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through its award-winning Tweed and Tokyo Smoke banners, the company reaches its adult-use consumers and has built a loyal following by focusing on top-quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; it has introduced additional hemp-derived CBD (cannabidiol) products to the United States through the company's First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.